IBOV 173,325.65 ▼ 0.03% IPSA 10,954.04 ▲ 0.52% IPC MEX 66,709.60 ▲ 0.88% MERVAL 3,281,979 — 0.00% COLCAP 2,301.34 ▲ 0.13% BVL PERÚ 56,620.35 — — USD/BRL5.06▼ 0.17% USD/MXN17.39▼ 0.11% USD/CLP936.20▲ 0.05% USD/COP3,209▼ 1.44% USD/PEN3.40▲ 0.08% USD/ARS1,479▲ 0.08% USD/UYU40.11▲ 1.23% USD/PYG6,045▲ 1.76% USD/BOB10.80▲ 2.69% USD/DOP58.00▼ 0.34% USD/CRC446.12▲ 1.06% USD/GTQ7.62▲ 2.33% USD/HNL26.74▲ 1.61% USD/NIO36.62▲ 0.72% USD/VES735.39▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.79▲ 0.55% USD/TTD6.73▲ 1.11% EUR/BRL5.78▼ 0.66% BRENT 93.57 ▲ 2.81% WTI 86.43 ▲ 1.79% IRON ORE 161.91 — — COPPER 6.51 ▼ 0.07% GOLD 4,135 ▲ 1.58% SILVER 59.73 ▲ 1.51% SOY 1,232 ▲ 0.98% CORN 482.25 ▲ 6.52% WHEAT 698.00 ▲ 2.95% COFFEE 318.50 ▼ 4.05% SUGAR 14.75 ▼ 0.87% ORANGE JUICE 146.00 ▲ 1.53% COTTON 80.43 ▲ 1.86% COCOA 5,400 ▼ 3.69% BEEF 223.05 ▼ 1.53% CATTLE 344.88 ▼ 2.02% LITHIUM 69.35 ▲ 0.39% PETR4 42.08 ▲ 1.01% VALE3 73.52 ▲ 1.77% ITUB4 42.70 ▲ 0.40% BBDC4 18.64 ▲ 0.49% ABEV3 15.86 ▲ 0.38% BBAS3 20.97 ▲ 0.43% B3SA3 15.39 ▲ 1.45% WEGE3 45.76 ▲ 7.75% PRIO3 59.07 ▲ 1.53% SUZB3 42.12 ▲ 1.18% RENT3 36.60 ▲ 0.14% AZZA3 17.28 ▼ 1.14% CSAN3 3.84 ▲ 1.59% RAIZ4 0.28 ▲ 3.70% PCAR3 2.73 — 0.00% GMAT3 3.88 ▲ 1.31% PSSA3 54.00 ▲ 0.97% CVCB3 1.18 ▲ 5.36% POSI3 3.70 ▲ 0.54% SLCE3 13.81 ▲ 0.44% NATU3 8.72 ▲ 0.11% BRKM5 5.84 ▲ 2.28% RANI3 7.97 ▲ 1.01% CSNA3 5.18 ▲ 2.37% CMIN3 5.70 ▲ 2.15% USIM5 8.55 ▲ 1.06% GGBR4 23.67 ▲ 0.77% ENEV3 25.44 ▲ 0.08% CPFE3 46.00 ▼ 0.86% CMIG4 11.02 — 0.00% EQTL3 38.67 ▼ 0.41% LREN3 13.44 ▲ 1.28% VIVT3 35.37 ▼ 1.20% RAIL3 13.41 ▲ 1.28% KLABIN 17.77 ▲ 1.02% RAIA DROGASIL 18.08 ▼ 0.28% RDOR3 34.07 ▲ 0.44% HAPV3 11.37 ▲ 1.16% FLRY3 16.67 ▲ 0.73% SMTO3 15.76 ▲ 1.16% UGPA3 32.08 ▲ 0.82% VBBR3 34.16 ▲ 0.62% BBSE3 41.58 ▲ 0.07% BPAC11 55.95 ▲ 1.05% CURY3 30.14 ▲ 0.63% AERI3 2.07 ▲ 1.47% VIVARA 21.41 — 0.00% COMPASS 24.50 ▲ 0.25% VAMOS 3.15 ▲ 1.94% SANB11 26.54 ▼ 2.46% ASAI3 8.42 ▲ 2.06% SBSP3 28.66 ▲ 0.21% WALMEX 49.15 ▼ 0.47% GMEXICO 209.54 ▲ 4.34% FEMSA 226.99 ▲ 0.01% CEMEX 22.07 ▲ 0.87% GFNORTE 185.80 ▲ 3.22% BIMBO 59.39 ▼ 0.18% TELEVISA 9.70 ▼ 0.10% AMX 22.76 ▲ 0.09% GAP 378.52 ▲ 0.09% ASUR 274.96 — 0.00% OMA 225.89 ▼ 0.24% KOF 181.05 ▲ 0.13% GRUMA 282.60 ▼ 1.74% KIMBER 38.40 ▲ 0.03% SQM-B 64,540 ▲ 1.80% COPEC 6,450 — 0.00% BSANTANDER 79.01 — 0.00% FALABELLA 5,919 ▲ 1.18% ENELAM 84.53 — 0.00% CENCOSUD 2,028 ▲ 1.14% CMPC 1,084 ▼ 0.38% BANCO CHILE 190.01 ▲ 0.03% LATAM AIR 24.20 ▼ 0.66% YPF 80,625 ▲ 1.80% GGAL 7,965 ▲ 1.53% PAMPA 5,475 ▲ 3.89% TXAR 679.00 ▲ 1.27% ALUAR 973.00 ▲ 1.41% TGS 9,710 ▲ 2.21% CEPU 2,340 ▲ 2.23% MIRGOR 16,775 ▼ 2.04% COME 42.87 ▼ 0.19% LOMA NEGRA 3,605 ▲ 0.91% BYMA 292.25 ▼ 0.51% TELECOM ARG 4,255 ▲ 2.65% ECOPETROL 16.53 ▲ 3.09% BANCOLOMBIA 83.64 — 0.00% GRUPO AVAL 5.09 ▲ 2.83% CREDICORP 391.10 ▲ 1.10% SOUTHERN COPPER 188.01 ▲ 7.39% BUENAVENTURA 31.25 ▲ 3.96% MERCADOLIBRE 1,823 ▼ 0.53% NUBANK 14.39 ▲ 2.86% XP 16.85 ▲ 0.30% PAGSEGURO 9.58 ▲ 3.12% STONE 11.26 ▲ 1.21% GLOBANT 32.10 ▼ 0.59% TECNOGLASS 45.15 ▼ 2.08% GAP AIRPORT 217.68 — 0.00% ASUR 274.96 — 0.00% OMA AIRPORT 104.23 ▲ 0.21% AMX ADR 26.09 ▼ 0.04% FEMSA ADR 130.35 — 0.00% CEMEX ADR 12.70 ▲ 1.68% PETROBRAS ADR 18.54 ▲ 1.92% VALE ADR 14.25 ▲ 1.06% ITAU ADR 8.40 ▲ 0.96% SANTANDER BR 5.40 ▲ 0.56% AMBEV ADR 3.11 ▲ 0.97% CSN 1.01 ▼ 0.50% GERDAU 4.64 ▼ 0.85% LATAM ADR 51.58 ▼ 0.31% BTC 65,724 ▼ 1.17% ETH 1,928 ▼ 0.02% SOL 77.62 ▼ 0.63% XRP 1.14 ▼ 0.47% BNB 571.14 ▼ 0.43% ADA 0.17 ▲ 0.09% DOGE 0.07 ▼ 1.22% AVAX 6.53 ▼ 0.48% LINK 8.61 ▼ 0.45% DOT 0.84 ▼ 1.16% LTC 46.72 ▼ 0.20% BCH 220.76 ▼ 1.31% TRX 0.33 ▲ 0.06% XLM 0.19 ▼ 1.97% HBAR 0.07 ▲ 2.02% NEAR 1.88 ▼ 2.85% ATOM 1.47 ▼ 1.15% AAVE 96.70 ▲ 1.18% SELIC 14.25% EMBRAER 83.17 ▲ 0.63% EMBRAER ADR 65.47 ▼ 0.70% JBS 11.95 ▼ 0.67% JBS BDR 60.63 ▲ 0.68% MBRF3 15.20 ▲ 0.60% MBRFY 2.95 — 0.00% INTER 5.58 ▼ 0.71% EGX 53,932 ▼ 0.11% USD/ZAR16.43▼ 0.26% USD/NGN 1,376 — 0.00% NIKKEI 66,116 ▼ 0.18% CSI300 4,717 ▼ 0.46% HSI 24,893 ▼ 0.95% NIFTY 23,996 ▼ 0.79% KOSPI 6,798 ▲ 0.74% JCI 6,334 ▼ 0.09% USD/JPY163.02▼ 0.09% USD/CNY6.76▼ 0.08% DAX 25,165 ▲ 0.61% CAC 8,454 ▲ 1.08% FTSE 10,744 ▲ 1.49% MIB 52,789 ▲ 0.96% IBEX 19,614 ▲ 1.21% STOXX 647.75 ▲ 0.71% EUR/USD1.14▲ 0.19% GBP/USD 1.3379 — 0.00% SPX 7,495 ▼ 0.19% DJI 52,197 ▼ 0.05% NDX 29,155 ▲ 1.93% RUT 2,987 ▲ 1.53% TSX 35,420 ▲ 0.14% VIX 17.37 ▲ 1.88% USD/CAD1.41▼ 0.20% US10Y 4.6420 ▲ 0.30% IBOV 173,325.65 ▼ 0.03% IPSA 10,954.04 ▲ 0.52% IPC MEX 66,709.60 ▲ 0.88% MERVAL 3,281,979 — 0.00% COLCAP 2,301.34 ▲ 0.13% BVL PERÚ 56,620.35 — — USD/BRL 5.06 ▼ 0.17% USD/MXN 17.39 ▼ 0.11% USD/CLP 936.20 ▲ 0.05% USD/COP 3,209 ▼ 1.44% USD/PEN 3.40 ▲ 0.08% USD/ARS 1,479 ▲ 0.08% USD/UYU 40.11 ▲ 1.23% USD/PYG 6,045 ▲ 1.76% USD/BOB 10.80 ▲ 2.69% USD/DOP 58.00 ▼ 0.34% USD/CRC 446.12 ▲ 1.06% USD/GTQ 7.62 ▲ 2.33% USD/HNL 26.74 ▲ 1.61% USD/NIO 36.62 ▲ 0.72% USD/VES 735.39 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.79 ▲ 0.55% USD/TTD 6.73 ▲ 1.02% EUR/BRL 5.78 ▼ 0.66% BRENT 93.57 ▲ 2.81% WTI 86.43 ▲ 1.79% IRON ORE 161.91 — — COPPER 6.51 ▼ 0.07% GOLD 4,135 ▲ 1.58% SILVER 59.73 ▲ 1.51% SOY 1,232 ▲ 0.98% CORN 482.25 ▲ 6.52% WHEAT 698.00 ▲ 2.95% COFFEE 318.50 ▼ 4.05% SUGAR 14.75 ▼ 0.87% ORANGE JUICE 146.00 ▲ 1.53% COTTON 80.43 ▲ 1.86% COCOA 5,400 ▼ 3.69% BEEF 223.05 ▼ 1.53% CATTLE 344.88 ▼ 2.02% LITHIUM 69.35 ▲ 0.39% PETR4 42.08 ▲ 1.01% VALE3 73.52 ▲ 1.77% ITUB4 42.70 ▲ 0.40% BBDC4 18.64 ▲ 0.49% ABEV3 15.86 ▲ 0.38% BBAS3 20.97 ▲ 0.43% B3SA3 15.39 ▲ 1.45% WEGE3 45.76 ▲ 7.75% PRIO3 59.07 ▲ 1.53% SUZB3 42.12 ▲ 1.18% RENT3 36.60 ▲ 0.14% AZZA3 17.28 ▼ 1.14% CSAN3 3.84 ▲ 1.59% RAIZ4 0.28 ▲ 3.70% PCAR3 2.73 — 0.00% GMAT3 3.88 ▲ 1.31% PSSA3 54.00 ▲ 0.97% CVCB3 1.18 ▲ 5.36% POSI3 3.70 ▲ 0.54% SLCE3 13.81 ▲ 0.44% NATU3 8.72 ▲ 0.11% BRKM5 5.84 ▲ 2.28% RANI3 7.97 ▲ 1.01% CSNA3 5.18 ▲ 2.37% CMIN3 5.70 ▲ 2.15% USIM5 8.55 ▲ 1.06% GGBR4 23.67 ▲ 0.77% ENEV3 25.44 ▲ 0.08% CPFE3 46.00 ▼ 0.86% CMIG4 11.02 — 0.00% EQTL3 38.67 ▼ 0.41% LREN3 13.44 ▲ 1.28% VIVT3 35.37 ▼ 1.20% RAIL3 13.41 ▲ 1.28% KLABIN 17.77 ▲ 1.02% RAIA DROGASIL 18.08 ▼ 0.28% RDOR3 34.07 ▲ 0.44% HAPV3 11.37 ▲ 1.16% FLRY3 16.67 ▲ 0.73% SMTO3 15.76 ▲ 1.16% UGPA3 32.08 ▲ 0.82% VBBR3 34.16 ▲ 0.62% BBSE3 41.58 ▲ 0.07% BPAC11 55.95 ▲ 1.05% CURY3 30.14 ▲ 0.63% AERI3 2.07 ▲ 1.47% VIVARA 21.41 — 0.00% COMPASS 24.50 ▲ 0.25% VAMOS 3.15 ▲ 1.94% SANB11 26.54 ▼ 2.46% ASAI3 8.42 ▲ 2.06% SBSP3 28.66 ▲ 0.21% WALMEX 49.15 ▼ 0.47% GMEXICO 209.54 ▲ 4.34% FEMSA 226.99 ▲ 0.01% CEMEX 22.07 ▲ 0.87% GFNORTE 185.80 ▲ 3.22% BIMBO 59.39 ▼ 0.18% TELEVISA 9.70 ▼ 0.10% AMX 22.76 ▲ 0.09% GAP 378.52 ▲ 0.09% ASUR 274.96 — 0.00% OMA 225.89 ▼ 0.24% KOF 181.05 ▲ 0.13% GRUMA 282.60 ▼ 1.74% KIMBER 38.40 ▲ 0.03% SQM-B 64,540 ▲ 1.80% COPEC 6,450 — 0.00% BSANTANDER 79.01 — 0.00% FALABELLA 5,919 ▲ 1.18% ENELAM 84.53 — 0.00% CENCOSUD 2,028 ▲ 1.14% CMPC 1,084 ▼ 0.38% BANCO CHILE 190.01 ▲ 0.03% LATAM AIR 24.20 ▼ 0.66% YPF 80,625 ▲ 1.80% GGAL 7,965 ▲ 1.53% PAMPA 5,475 ▲ 3.89% TXAR 679.00 ▲ 1.27% ALUAR 973.00 ▲ 1.41% TGS 9,710 ▲ 2.21% CEPU 2,340 ▲ 2.23% MIRGOR 16,775 ▼ 2.04% COME 42.87 ▼ 0.19% LOMA NEGRA 3,605 ▲ 0.91% BYMA 292.25 ▼ 0.51% TELECOM ARG 4,255 ▲ 2.65% ECOPETROL 16.53 ▲ 3.09% BANCOLOMBIA 83.64 — 0.00% GRUPO AVAL 5.09 ▲ 2.83% CREDICORP 391.10 ▲ 1.10% SOUTHERN COPPER 188.01 ▲ 7.39% BUENAVENTURA 31.25 ▲ 3.96% MERCADOLIBRE 1,823 ▼ 0.53% NUBANK 14.39 ▲ 2.86% XP 16.85 ▲ 0.30% PAGSEGURO 9.58 ▲ 3.12% STONE 11.26 ▲ 1.21% GLOBANT 32.10 ▼ 0.59% TECNOGLASS 45.15 ▼ 2.08% GAP AIRPORT 217.68 — 0.00% ASUR 274.96 — 0.00% OMA AIRPORT 104.23 ▲ 0.21% AMX ADR 26.09 ▼ 0.04% FEMSA ADR 130.35 — 0.00% CEMEX ADR 12.70 ▲ 1.68% PETROBRAS ADR 18.54 ▲ 1.92% VALE ADR 14.25 ▲ 1.06% ITAU ADR 8.40 ▲ 0.96% SANTANDER BR 5.40 ▲ 0.56% AMBEV ADR 3.11 ▲ 0.97% CSN 1.01 ▼ 0.50% GERDAU 4.64 ▼ 0.85% LATAM ADR 51.58 ▼ 0.31% BTC 65,724 ▼ 1.17% ETH 1,928 ▼ 0.02% SOL 77.62 ▼ 0.63% XRP 1.14 ▼ 0.47% BNB 571.14 ▼ 0.43% ADA 0.17 ▲ 0.09% DOGE 0.07 ▼ 1.22% AVAX 6.53 ▼ 0.48% LINK 8.61 ▼ 0.45% DOT 0.84 ▼ 1.16% LTC 46.72 ▼ 0.20% BCH 220.76 ▼ 1.31% TRX 0.33 ▲ 0.06% XLM 0.19 ▼ 1.97% HBAR 0.07 ▲ 2.02% NEAR 1.88 ▼ 2.85% ATOM 1.47 ▼ 1.15% AAVE 96.70 ▲ 1.18% SELIC 14.25% EMBRAER 83.17 ▲ 0.63% EMBRAER ADR 65.47 ▼ 0.70% JBS 11.95 ▼ 0.67% JBS BDR 60.63 ▲ 0.68% MBRF3 15.20 ▲ 0.60% MBRFY 2.95 — 0.00% INTER 5.58 ▼ 0.71% EGX 53,932 ▼ 0.11% USD/ZAR 16.44 ▼ 0.13% USD/NGN 1,376 — 0.00% NIKKEI 66,116 ▼ 0.18% CSI300 4,717 ▼ 0.46% HSI 24,893 ▼ 0.95% NIFTY 23,996 ▼ 0.79% KOSPI 6,798 ▲ 0.74% JCI 6,334 ▼ 0.09% USD/JPY 163.07 ▼ 0.04% USD/CNY 6.7610 ▲ 0.06% DAX 25,165 ▲ 0.61% CAC 8,454 ▲ 1.08% FTSE 10,744 ▲ 1.49% MIB 52,789 ▲ 0.96% IBEX 19,614 ▲ 1.21% STOXX 647.75 ▲ 0.71% EUR/USD 1.1418 ▲ 0.12% GBP/USD 1.3379 — 0.00% SPX 7,495 ▼ 0.19% DJI 52,197 ▼ 0.05% NDX 29,155 ▲ 1.93% RUT 2,987 ▲ 1.53% TSX 35,420 ▲ 0.14% VIX 17.37 ▲ 1.88% USD/CAD 1.4083 ▼ 0.16% US10Y 4.6420 ▲ 0.30%
since 2009
Wednesday, July 22, 2026

Covid-19: Updated count of reported injuries and deaths after vaccines in EU member states (February 12)

By · February 25, 2022 · 5 min read

Daily Brief

The morning intel from across Latin America. Free.

By subscribing you agree to our privacy policy. We never share your email.

RIO DE JANEIRO, BRAZIL – EudraVigilance, the European database where adverse reactions to vaccines are reported, had collected as of February 12, 39.997 reports of deaths and 3.666.011 reports of injuries (half of them serious) from people who received some of the four experimental injections licensed at this time within the member countries of the European Union.

In the previous report, dated January 1, the number of reported deaths was 36,257, and injuries were 3,244,052.

EudraVigilance is widely acknowledged to be vastly underreported. The effective case numbers are therefore likely to be significantly higher.

Read also: Check out our coverage on curated alternative narratives

EudraVigilance was launched by the European Medicines Agency in 2012 to provide public access to reports of suspected side effects. These reports are submitted electronically to EudraVigilance by national medicines regulatory authorities and pharmaceutical companies that hold marketing authorizations (licenses) for drugs.

MODERNA – COVID-19 mRNA VACCINE (CX-024414)
PFIZER-BioNTech – COVID-19 mRNA VACCINE
ASTRAZENECA – COVID-19 VACCINE (CHADOX1 NCOV-19)
JANSSEN – COVID-19 VACCINE (AD26.COV2.S )

Of the total number of registered injuries, almost half (1.727.226) are severe injuries*.

*According to Eudravigilance, “seriousness provides information on the suspected undesirable effect; it can be classified as ‘serious’ if it corresponds to a medical event that results in death, is life-threatening, requires hospitalization, results in another medically important condition, or prolongs existing hospitalization, results in persistent or significant disability or incapacity, or is a congenital anomaly/congenital disability.”

RT
Ask Rio Times
17 years of Latin America reporting, on demand.
Open the full Ask Rio Times →
One-stop reference
Company Intelligence
Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.
Browse the directory →

As we have discussed in previous reports, we have the following information thanks to a subscriber to the Health Impact News website in Europe, who is undertaking the work of expanding on the details in the reports of each of the four COVID-19 injections that we include here.

This subscriber volunteered to do this, and it is a lot of work to tabulate each reaction with injuries and deaths, as there is no place in the EudraVigilance system to tabulate all the results.

It should be noted that, just as not all reported deaths and injuries need necessarily be vaccine-related, it is well known that these reports represent a very minimal amount of the actual cases, as most death and injury events are not being reported.

Here are the EudraVigilance data summarized up to February 12, 2021.

Total reactions for the Pfizer/BioNTech vaccine:
18,185 deaths and 1,791,261 injuries

  • 50,761 Blood and lymphatic system disorders incl. 254 deaths
  • 61,233 Cardiac disorders incl. 2,638 deaths
  • 547 Congenital, familial, and genetic disorders incl. 55 deaths
  • 23,657 Hearing and labyrinth disorders incl. 12 deaths
  • 2,077 Endocrine disorders incl. 8 deaths
  • 27,111 Eye disorders incl. 39 deaths
  • 138,253 Gastrointestinal disorders incl. 706 deaths
  • 443,764 General disorders and administration site conditions incl. 5,190 deaths
  • 2,025 Hepatobiliary disorders incl. 95 deaths
  • 19,243 Immune system disorders incl. 99 deaths
  • 84,884 Infections and infestations incl. 1,931 deaths
  • 35,665 Injuries, poisoning and procedural complications, incl. 349 deaths
    44,308 Investigations incl. 520 deaths
  • 11,795 Disorders of metabolism and nutrition incl. 289 deaths
  • 209,669 Musculoskeletal and connective tissue disorders, incl. 228 deaths
  • 1,744 Benign, malignant and unspecified neoplasms (incl. cysts and polyps) incl. 166 deaths
  • 290,349 Nervous system disorders incl. 1,926 deaths
  • 2,658 Pregnancy, puerperium and perinatal conditions incl. 75 deaths
  • 262 Product problems incl. 3 deaths
  • 32,195 Psychiatric disorders incl. 216 deaths
  • 6,509 Renal and urinary disorders incl. 272 deaths
  • 74,588 Reproductive system and breast disorders incl. 6 deaths
  • 75,926 Respiratory, thoracic and mediastinal disorders incl. 1,932 deaths
  • 81,815 Disorders of skin and subcutaneous tissue incl. 146 deaths
  • 4,127 Social circumstances incl. 23 deaths
  • 21,849 Surgical and medical procedures incl. 208 deaths
  • 44,247 Vascular disorders incl. 799 deaths

Total reactions to the Moderna vaccine:
11,138 deaths and 573,035 injuries

  • 13,383 Blood and lymphatic system disorders incl. 120 deaths
  • 19,462 Cardiac disorders incl. 1,169 deaths
  • 198 Congenital, familial, and genetic disorders incl. 12 deaths
  • 6,688 Hearing and labyrinth disorders incl. 8 deaths
  • 533 Endocrine disorders incl. 6 deaths
  • 7,856 Ocular disorders incl. 35 deaths
  • 46,468 Gastrointestinal disorders incl. 416 deaths
  • 152,534 General disorders and conditions at place of administration incl. 3,672 deaths
  • 819 Hepatobiliary disorders incl. 55 deaths
  • 5,683 Immune system disorders incl. 21 deaths
  • 24,462 Infections and infestations incl. 1,051 deaths
  • 10,555 Injuries, intoxications and procedural complications, incl. 211 deaths
  • 12,633 Investigations incl. 395 deaths
  • 4,996 Disorders of metabolism and nutrition incl. 268 deaths
  • 70,107 Disorders of musculoskeletal and connective tissue, incl. 221 deaths
  • 700 Benign, malignant, malignant and unspecified neoplasms (incl. cysts and polyps) incl. 86 deaths
  • 95,946 Nervous system disorders incl. 1,040 deaths
  • 925 Pregnancy, puerperium and perinatal conditions incl. 10 deaths
  • 101 Product problems incl. 4 deaths
  • 9,813 Psychiatric disorders incl. 181 deaths
  • 3,157 Renal and urinary disorders incl. 218 deaths
  • 14,047 Reproductive system and breast disorders incl. 9 deaths
  • 24,308 Respiratory, thoracic, and mediastinal disorders incl. 1,178 deaths
  • 29,172 Disorders of skin and subcutaneous tissue incl. 96 deaths
  • 2,325 Social circumstances incl. 45 deaths
  • 3,585 Surgical and medical procedures incl. 206 deaths
  • 12,579 Vascular disorders incl. 405 deaths

Total reactions for the Oxford/AstraZeneca vaccine:
8,174 deaths and 1,170,321 injuries.

  • 4,038 Blood and lymphatic system disorders incl. 279 deaths
  • 21,330 Cardiac disorders incl. 854 deaths
  • 241 Familial and genetic congenital disorders incl. 9 deaths
  • 13,580 Hearing and labyrinth disorders incl. 7 deaths
  • 709 Endocrine disorders incl. 6 deaths
  • 20,310 Ocular disorders incl. 32 deaths
  • 108,425 Gastrointestinal disorders incl. 447 deaths
  • 309,230 General disorders and administration site conditions incl. 1,893 deaths
  • 1,062 Hepatobiliary disorders incl. 70 deaths
  • 5,495 Immune system disorders incl. 40 deaths
  • 43,810 Infections and infestations incl. 634 deaths
  • 13,918 Poisoning due to injuries and procedural complications, incl. 201 deaths
  • 26,112 Investigations incl. 206 deaths
  • 13,147 Disorders of metabolism and nutrition incl. 132 deaths
  • 170,055 Disorders of musculoskeletal and connective tissue, incl. 171 deaths
  • 769 Benign, malignant and unspecified neoplasms (incl. cysts and polyps) , incl. 42 deaths
  • 236,745 Nervous system disorders, incl. 1,199 deaths
  • 631 Pregnancy, puerperium and perinatal conditions incl. 21 deaths
  • 199 Product problems incl. 1 death
  • 21,273 Psychiatric disorders incl. 73 deaths
  • 4,416 Renal and urinary disorders incl. 82 deaths
  • 17,181 Reproductive system and breast disorders incl. 3 deaths
  • 42,021 Respiratory, thoracic and mediastinal disorders incl. 1,119 deaths
  • 52,622 Disorders of skin and subcutaneous tissue, incl. 69 deaths
  • 1,657 Social circumstances incl. 9 deaths
  • 2,217 Surgical and medical procedures incl. 33 deaths
  • 29,128 Vascular disorders incl. 542 deaths

Total reactions for the Johnson & Johnson vaccine:
2,500 deaths and 131,394 injuries

  • 1,272 Blood and lymphatic system disorders incl. 54 deaths
  • 2,671 Cardiac disorders incl. 211 deaths
  • 44 Congenital, familial, and genetic disorders incl. 1 death
  • 1,382 Disorders of the ear and labyrinth incl. 3 deaths
  • 109 Endocrine disorders incl. 2 deaths
  • 1,710 Eye disorders incl. 10 deaths
  • 9,791 Gastrointestinal disorders incl. 94 deaths
  • 35,428 General disorders and alterations at site of administration incl. 708 deaths
  • 160 Hepatobiliary disorders incl. 15 deaths
  • 572 Immune system disorders, incl. 10 deaths
  • 8,881 Infections and infestations incl. 211 deaths
  • 1,230 Injuries, intoxications and procedural complications, incl. 26 deaths
  • 6,393 Investigations incl. 134 deaths
  • 793 Disorders of metabolism and nutrition, incl. 63 deaths
  • 17,493 Musculoskeletal and connective tissue disorders, incl. 57 deaths
  • 95 Benign, malignant and unspecified neoplasms (incl. cysts and polyps) , incl. 9 deaths
  • 23,989 Nervous system disorders, incl. 248 deaths
  • 61 Pregnancy, puerperium and perinatal conditions incl. 1 death
  • 31 Product problems
  • 1,844 Psychiatric disorders incl. 24 deaths
  • 560 Renal and urinary disorders incl. 32 deaths
  • 3,189 Reproductive system and breast disorders incl. 7 deaths
  • 4,649 Respiratory, thoracic and mediastinal disorders incl. 314 deaths
  • 3,894 Skin and subcutaneous tissue disorders incl. 12 deaths
  • 429 Social circumstances incl. 4 deaths
  • 932 Medical and surgical procedures, incl. 75 deaths
  • 3,792 Vascular disorders incl. 175 deaths

This is public information funded by the European Medicines Agency (EMA), and anyone can use the EudraVigilance system and verify this data.

Join us on Telegram: t.me/theriotimes

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.